These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26432005)

  • 1. HMGCR positively regulated the growth and migration of glioblastoma cells.
    Qiu Z; Yuan W; Chen T; Zhou C; Liu C; Huang Y; Han D; Huang Q
    Gene; 2016 Jan; 576(1 Pt 1):22-7. PubMed ID: 26432005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells.
    Chushi L; Wei W; Kangkang X; Yongzeng F; Ning X; Xiaolei C
    Gene; 2016 Aug; 587(1):42-7. PubMed ID: 27085483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc.
    Zhong C; Fan L; Yao F; Shi J; Fang W; Zhao H
    Tumour Biol; 2014 May; 35(5):4123-9. PubMed ID: 24390662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma.
    Dong L; Xue L; Zhang C; Li H; Cai Z; Guo R
    Mol Med Rep; 2019 Jan; 19(1):524-532. PubMed ID: 30483734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription.
    Nawaz Z; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Sci Rep; 2016 Jun; 6():27753. PubMed ID: 27291091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
    Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S
    Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.
    Bhardwaj A; Singh H; Trinidad CM; Albarracin CT; Hunt KK; Bedrosian I
    Breast Cancer Res; 2018 Dec; 20(1):150. PubMed ID: 30537987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells.
    Göbel A; Breining D; Rauner M; Hofbauer LC; Rachner TD
    Cell Death Dis; 2019 Jan; 10(2):91. PubMed ID: 30692522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non-Small Cell Lung Carcinogenesis.
    Zhang T; Bai R; Wang Q; Wang K; Li X; Liu K; Ryu J; Wang T; Chang X; Ma W; Bode AM; Xia Q; Song Y; Dong Z
    Cancer Prev Res (Phila); 2019 Dec; 12(12):837-848. PubMed ID: 31554629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
    Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
    Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A second gene for peroxisomal HMG-CoA reductase? A genomic reassessment.
    Breitling R; Krisans SK
    J Lipid Res; 2002 Dec; 43(12):2031-6. PubMed ID: 12454262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate esters interact with HMG-CoA reductase membrane domain to induce its degradation.
    Toyota Y; Yoshioka H; Sagimori I; Hashimoto Y; Ohgane K
    Bioorg Med Chem; 2020 Jul; 28(14):115576. PubMed ID: 32616181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.
    Sakai K; Nagashima S; Wakabayashi T; Tumenbayar B; Hayakawa H; Hayakawa M; Karasawa T; Ohashi K; Yamazaki H; Takei A; Takei S; Yamamuro D; Takahashi M; Yagyu H; Osuga JI; Takahashi M; Tominaga SI; Ishibashi S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2590-2600. PubMed ID: 30354246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
    Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
    Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene.
    Ohashi K; Osuga J; Tozawa R; Kitamine T; Yagyu H; Sekiya M; Tomita S; Okazaki H; Tamura Y; Yahagi N; Iizuka Y; Harada K; Gotoda T; Shimano H; Yamada N; Ishibashi S
    J Biol Chem; 2003 Oct; 278(44):42936-41. PubMed ID: 12920113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of the mevalonate pathway promotes transformation.
    Clendening JW; Pandyra A; Boutros PC; El Ghamrasni S; Khosravi F; Trentin GA; Martirosyan A; Hakem A; Hakem R; Jurisica I; Penn LZ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15051-6. PubMed ID: 20696928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luciferase-based HMG-CoA reductase degradation assay for activity and selectivity profiling of oxy(lano)sterols.
    Sagimori I; Yoshioka H; Hashimoto Y; Ohgane K
    Bioorg Med Chem; 2020 Feb; 28(3):115298. PubMed ID: 31902650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
    Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plant oxysterol, 28-homobrassinolide binds HMGCoA reductase catalytic cleft: stereoselective avidity affects enzyme function.
    Mukherjee V; Vijayalaksmi D; Gulipalli J; Premalatha R; Sufi SA; Velan A; Srikumar K
    Mol Biol Rep; 2016 Oct; 43(10):1049-58. PubMed ID: 27585573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction.
    Wang HY; Yu P; Chen XS; Wei H; Cao SJ; Zhang M; Zhang Y; Tao YG; Cao DS; Qiu F; Cheng Y
    Acta Pharmacol Sin; 2022 Jun; 43(6):1594-1604. PubMed ID: 34588618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.